Patents by Inventor Jorgen Soberg Petersen

Jorgen Soberg Petersen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF CARDIAC CONDITIONS
    Publication number: 20130157953
    Abstract: The invention relates to the treatment of cardiac dysfunction. In particular, certain compounds, believed to be glucagon-GLP-1 dual agonist compounds, exert a positive inotropic effect while preserving the energy balance of the heart, and so may be superior to known inotropic agents such as dobutamine, norepinephrine and glucagon.
    Type: Application
    Filed: January 20, 2011
    Publication date: June 20, 2013
    Applicant: Zealand Pharma A/S
    Inventors: Jørgen Søberg Petersen, Anne Louise Kjoelbye, Marie Skovgaard, Henrik Duelund Pedersen, Lene Axelsen, Ditte Riber, Eddi Meier, Rie Schultz Hansen, Keld Fosgerau, Bjarne Due Larsen
  • Modified lysine-mimetic compounds
    Patent number: 8431540
    Abstract: Lysine mimetic compounds having useful pharmacological activity such as antiarrhythmic activity and desirable bioavailability properties are disclosed.
    Type: Grant
    Filed: September 16, 2011
    Date of Patent: April 30, 2013
    Assignee: Zealand Pharma A/S
    Inventors: Bjarne Due Larsen, Jørgen Søberg Petersen, Ketil Jørgen Haugan, John A. Butera, James K. Hennan, Edward H. Kerns, Evgueni Lvovich Piatnitski
  • MODIFIED LYSINE-MIMETIC COMPOUNDS
    Publication number: 20120245106
    Abstract: Lysine mimetic compounds having useful pharmacological activity such as antiarrhythmic activity and desirable bioavailability properties are disclosed.
    Type: Application
    Filed: September 16, 2011
    Publication date: September 27, 2012
    Applicant: Zealand Pharma A/S
    Inventors: Bjarne Due Larsen, Jørgen Søberg Petersen, Ketil Jørgen Haugan, John A. Butera, James K. Hennan, Edward H. Kerns, Evgueni Lvovich Piatnitski
  • Modified lysine-mimetic compounds
    Patent number: 8026272
    Abstract: Lysine mimetic compounds having useful pharmacological activity such as antiarrhythmic activity and desirable bioavailability properties are disclosed.
    Type: Grant
    Filed: October 30, 2009
    Date of Patent: September 27, 2011
    Assignee: Zealand Pharma A/S
    Inventors: Bjarne Due Larsen, Jørgen Søberg Petersen, Ketil Jørgen Haugan, John A. Butera, James K. Hennan, Edward H. Kerns, Evgueni Lvovich Piatnitski
  • MODIFIED LYSINE-MIMETIC COMPOUNDS
    Publication number: 20100249206
    Abstract: Lysine mimetic compounds having useful pharmacological activity such as antiarrhythmic activity and desirable bioavailability properties are disclosed.
    Type: Application
    Filed: October 30, 2009
    Publication date: September 30, 2010
    Inventors: Bjarne Due Larsen, Jorgen Soberg Petersen, Ketil Jorgen Haugan, John A. Butera, James K. Hennan, Edward H. Kerns, Evgueni Lvovich Piatnitski
  • Antiarrhythmic peptides
    Patent number: 7737113
    Abstract: Disclosed are novel peptides including antiarrhythmic peptides that have improved stability. Further disclosed are compositions that include such peptides and methods of using the compositions particularly as medicaments.
    Type: Grant
    Filed: February 4, 2004
    Date of Patent: June 15, 2010
    Assignee: Zealand Pharma A/S
    Inventors: Bjarne Due Larsen, Jørgen Søberg Petersen, Eddi Meier, Anne Louise Kjolbye, Niklas Rye Jorgensen, Morten Schak Nielsen, James B. Martins, Niels-Henrik Holstein-Rathlou
  • Modified lysine-mimetic compounds
    Patent number: 7622496
    Abstract: Lysine mimetic compounds having useful pharmacological activity such as antiarrhythmic activity and desirable bioavailability properties are disclosed.
    Type: Grant
    Filed: December 21, 2006
    Date of Patent: November 24, 2009
    Assignees: Zealand Pharma A/S, Wyeth
    Inventors: Bjarne Due Larsen, Jørgen Søberg Petersen, Ketil Jørgen Haugan, John A. Butera, James K. Hennan, Edward H. Kerns, Evgueni L. Piatnitski
  • Medical uses of intercellular communication facilitating compounds
    Patent number: 7585839
    Abstract: Disclosed are novel peptides including antiarrhythmic peptides that have improved stability. Further disclosed are compositions that include such peptides and methods of using the compositions particularly as medicaments.
    Type: Grant
    Filed: August 22, 2003
    Date of Patent: September 8, 2009
    Assignee: Zealand Pharma A/S
    Inventors: Bjarne Due Larsen, Jorgen Soberg Petersen, Eddi Meier, Anne Louise Kjolbye, Niklas Rye Jorgensen, Morten Schak Neilsen, Neils-Henrik Holstein-Rathlou, James B. Martins, Peter Holme Jensen
  • Diuretic peptide conjugates
    Patent number: 7550425
    Abstract: Disclosed are a variety of peptide conjugates represented by the following general formula: R1-Z-X-Z?-R2 including methods of making and using such conjugates. Also provided are antibodies that specifically bind the peptide conjugates. The present invention has a wide spectrum of important applications including use in the treatment of disorders impacted by nociceptin and related opioid-like peptides.
    Type: Grant
    Filed: April 8, 2005
    Date of Patent: June 23, 2009
    Assignee: Zealand Pharma A/S
    Inventors: Bjarne Due Larsen, Jørgen Søberg Petersen, Daniel R. Kapusta, Kenneth W. Harlow
  • Compositions and methods for modulating connexin hemichannels
    Patent number: 7153822
    Abstract: Disclosed are compositions and methods for modulating hemichannel function in a cell, tissue or organ. The invention also relates to useful screens for detecting such compounds, particularly those capable of modulating connexin phosphorylation. Further provided are therapeutic methods for preventing or treating conditions impacted by undesired hemichannel function in a mammal such as heart arrhythmia.
    Type: Grant
    Filed: January 29, 2003
    Date of Patent: December 26, 2006
    Assignee: Wyeth
    Inventors: Peter Holme Jensen, Bjarne Due Larsen, Lars Bo Laurenborg Hansen, Jørgen Søberg Petersen, Soren Neve, Morten Schak Nielsen, Eddi Meier, Eva Steiness
  • Compositions and methods for modulating connexin hemichannels
    Publication number: 20040092429
    Abstract: Disclosed are compositions and methods for modulating hemichannel function in a cell, tissue or organ. The invention also relates to useful screens for detecting such compounds, particularly those capable of modulating connexin phosphorylation. Further provided are therapeutic methods for preventing or treating conditions impacted by undesired hemichannel function in a mammal such as heart arrhythmia.
    Type: Application
    Filed: January 29, 2003
    Publication date: May 13, 2004
    Applicant: Zealand Pharma A/S
    Inventors: Peter Holme Jensen, Bjarne Due Larsen, Lars Bo Laurenborg Hansen, Jorgen Soberg Petersen, Soren Neve, Morten Schak Nielsen, Eddi Meier, Eva Steiness
  • Novel antiarrythmic peptides
    Publication number: 20030092609
    Abstract: Disclosed are novel peptides including antiarrhythmic peptides that have improved stability. Further disclosed are compositions that include such peptides and methods of using the compositions particularly as medicaments.
    Type: Application
    Filed: February 22, 2001
    Publication date: May 15, 2003
    Inventors: Bjarne Due Larsen, Jorgen Soberg Petersen, Eddi Meier, Anne Louise Kjolbye, Niklas Rye Jorgensen, Morten Schak Nielsen, James B. Martins, Niels-Henrik Holstein-Rathlou
  • Novel peptide conjugates
    Publication number: 20030040472
    Abstract: Disclosed are a variety of peptide conjugates represented by the following general formula.
    Type: Application
    Filed: June 15, 2001
    Publication date: February 27, 2003
    Applicant: Zealand Pharmaceuticals A/S
    Inventors: Bjarne Due Larsen, Jorgen Soberg Petersen, Daniel R. Kapusta, Kenneth W. Harlow